Menopause

Poor sleep occurs frequently among midlife women, which is significantly linked to childhood and adult trauma, according to a prospective study presented at the 2020 Virtual Annual Meeting of the North American Menopause Society (NAMS).

This article is based on information presented at the 2020 Virtual Annual Meeting of the North American Menopause Society (NAMS). According to NAMS, all presentations have been pre-recorded and now are available for on-demand viewing beginning Sept. 28 through Sept. 21, 2021.

Postmenopausal women are significantly more likely to meet criteria for metabolic syndrome than are premenopausal women, according to a cross-sectional analysis of women aged 45 to 85.

Perimenopausal women with prior depression exhibit significantly more depressive symptoms, more menopausal symptoms, and more sleep disturbances than perimenopausal women without prior depression, according to a study from Switzerland.

Considerable heterogeneity exists in reported outcomes and measures used in clinical trials of treatments for genitourinary syndrome of menopause (GSM), which impacts between 40% and 60% of postmenopausal women, according to a systematic review in the journal Menopause.

A new study finds that dairy products do not prevent age-related bone loss or fractures in menopausal women.

Women who were in the top third of hot flash severity showed a 67% increase in cortisol, whereas those in the bottom third of hot flash severity showed only a 30% increase.

A prospective study of generally healthy perimenopausal women has concluded that low bone mineral density (BMD) is significantly linked with periodontal disease in women over 58 years old, and independent of tobacco consumption or oral hygiene.

A study from the Long Island Breast Cancer Study Project (LIBCSP) investigated the association between menopausal hormone therapy (MHT) and mortality outcomes among breast cancer survivors.

Postmenopausal women who breastfed for at least 6 months cumulatively have a significantly lower incidence of subclinical atherosclerosis compared to postmenopausal women who breastfeed for a shorter duration, according to a cross-sectional study in the journal Gynecological Endocrinology.

Lack of patient knowledge about the natural process of menopause and lifestyle interventions are two major challenges to symptom control.

A peak in hot fl ash reports was observed in July, while January had a trough in hot fl ash reports.

The authors noted that, although recent guidelines embrace using history of menopause before age 40 to refine atherosclerotic cardiovascular disease (ASCVD) risk assessments in middle-aged women, “robust data on cardio-vascular disease risk in this population is lacking.”

Allegations in this complex case include negligence in performing laparoscopic hysterectomy and delaying treatment of bladder injury.

The review concluded that the highest increase in MD is among current users of HRT, particularly those taking continuous estrogen plus progestin (CEP).

Isoflavones significantly improve bone mineral density (BMD) and are safe in postmenopausal women, according to a systematic review and meta-analysis of 63 randomized controlled trials involving 6,427 postmenopausal women.

New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).

The overview underscores the importance of considering a woman’s age and time since menopause.

The North American Menopause Society (NAMS) will hold its 31st Annual Meeting at the Gaylord Rockies Hotel in Denver from Sept. 30 to Oct. 3, 2020.

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.

For postmenopausal women with at least one vulvovaginal atrophy (VVA) symptom, the presence of physician-confirmed VVA is linked to significant impaired sexual function, according to a study from the European Vulvovaginal Epidemiological Survey (EVES).

Social inequalities profoundly impact South Korean postmenopausal women who have metabolic syndrome and osteoporosis, according to a cross-sectional study in the journal Menopause.

The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.

New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms but not during their reported menopause transition, according to new research.